Show simple item record

dc.contributor.authorWeigum, Shannon E. ( Orcid Icon 0000-0002-9485-1062 )
dc.contributor.authorSutton, Melissa ( )
dc.contributor.authorBarnes, Eugenia ( )
dc.contributor.authorMiller, Sarah ( )
dc.contributor.authorBetancourt, Tania ( )
dc.date.accessioned2020-05-26T18:37:28Z
dc.date.available2020-05-26T18:37:28Z
dc.date.issued2014-08-27
dc.identifier.citationWeigum, S. E., Sutton, M., Barnes, E., Miller, S., & Betancourt, T. (2014). Targeting hepatocellular carcinoma with aptamer-functionalized PLGA/PLA-PEG nanoparticles. Proceedings of the SPIE, Biosensing and Nanomedicine VII, 916605.en_US
dc.identifier.urihttps://digital.library.txstate.edu/handle/10877/10314
dc.description.abstractHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, particularly in regions where chronic Hepatitis B and C infections are common. Nanoparticle assemblies that incorporate high-affinity aptamers which specifically bind malignant hepatocellular carcinoma cells could be useful for targeted drug delivery or enhancing contrast with existing ablation therapies. The in vitro interactions of a tumor-specific aptamer, TLS11a, were characterized in a hepatoma cell line via live-cell fluorescence imaging, SDS-PAGE and Western Blotting techniques. Cell surface binding of the aptamer-AlexaFluor®546 conjugate was found to occur within 20 minutes of initial exposure, followed by internalization and localization to late endosomes or lysosomes using a pH-sensitive LysoSensor™ Green dye and confocal microscopy. Aptamer-functionalized polymer nanoparticles containing poly(lactic-co-glycolic acid) (PLGA) and poly(lactide)-b-poly(ethylene glycol) (PLA-PEG) were then prepared by nanoprecipitation and passively loaded with the chemotherapeutic agent, doxorubicin, yielding spherical nanoparticles approximately 50 nm in diameter. Targeted drug delivery and cytotoxicity was assessed using live/dead fluorescent dyes and a MTT colorimetric viability assay with elevated levels of cell death found in cultures treated with either the aptamer-coated and uncoated polymer nanoparticles. Identification and characterization of the cell surface protein epitope(s) recognized by the TLS11a aptamer are ongoing along with nanoparticle optimization, but these preliminary studies support continued investigation of this aptamer and functionalized nanoparticle conjugates for targeted labeling and drug delivery within malignant hepatocellular carcinomas.en_US
dc.formatText
dc.format.extent11 pages
dc.format.medium1 file (.pdf)
dc.language.isoen_USen_US
dc.publisherSociety of Photo-optical Instrumentation Engineersen_US
dc.sourceSociety of Photo-optical Instrumentation Engineers (SPIE) NanoScience + Engineering, 2014, San Diego, California, United States.
dc.subjectCanceren_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectAptameren_US
dc.subjectNanoparticlesen_US
dc.subjectDrug deliveryen_US
dc.titleTargeting Hepatocellular Carcinoma with Aptamer-functionalized PLGA/PLA-PEG Nanoparticlesen_US
txstate.documenttypeArticle
dc.identifier.doihttps://doi.org/10.1117/12.2062283
txstate.departmentBiology
txstate.departmentChemistry and Biochemistry
txstate.departmentMaterials Science, Engineering, and Commercialization


Download

Thumbnail

This item appears in the following Collection(s)

Show simple item record